glp-1 medications vs. bariatric surgery Medication for Weight Loss: Options Matter Metabolic and bariatric surgery versus

Side effects are common in the first week of treatment as your body adjusts to the medication

The 4 to 8 mg jump is the largest absolute increase in the standard protocol and carries the highest side effect risk

**Based on a placebo-controlled, crossover clinical study of 19 participants who took identical test meals, once with Flatter Me and once with a placebo

Semaglutide (Ozempic, Wegovy, Rybelsus) Semaglutide is the most widely prescribed GLP-1 receptor agonist, available as both injectable (Ozempic for diabetes, Wegovy for weight management) and oral (Rybelsus) formulations

Meanwhile, when it comes to ultra-high net worth individuals, or UNHWIs, Kearnys analysts found that Japan, Italy, India, Hong Kong and Denmark will add around 7,400 of the worlds richest people, with a noteworthy 35% growth of UNHWI in India

It's important to note that large cardiovascular outcome trials have not shown an increased risk of major adverse cardiovascular events or atrial fibrillation with these medications